Delivery Order SPE2DB25D9305-SPE2DB26FQAAJ
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain division on October 17, 2025, for VABYSMO 6 mg/0.05 ml syringes valued at $5,966.88 with a firm fixed-price structure. The delivery order, which carries no set-aside designation, is issued under DMS Pharmaceutical Group's broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V)...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for the supply of Vabysmo 6 mg/0.05 mL syringes valued at $4,475.16. The award, issued on July 31, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. This delivery order does not utilize a set-aside designation and represents a continuation of the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $11,933.76 on July 18, 2025, for the supply of Vabysmo 6 mg/0.05 mL syringes. The award carries an ultimate completion date of August 8, 2025, and represents a specific delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at approximately $500...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,950.32 by the Defense Logistics Agency (DLA) on June 5, 2025. The contract calls for the delivery of Vabysmo 6 mg/0.05 mL syringes, a pharmaceutical product used in ophthalmology treatment. This delivery order represents a single issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- The Department of Defense Medical Supply Chain awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $11,933.76 for Vabysmo 6 mg/0.05 ml syringes. The award was made on September 22, 2025, with an ultimate completion date of October 14, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete openly based on its established...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $37,293.00 on September 22, 2025, for the supply of VABYSMO 6 MG/0.05 ML syringes. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of October 14, 2025. The place of performance is located in Park Ridge, Illinois, and the award was made by the Defense Logistics Agency's Medical Supply...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $22,375.80 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on September 2, 2025, with an ultimate completion date of September 23, 2025. The delivery order covers VABYSMO 6 mg/0.05 ml syringes, a prescription ophthalmic medication used to treat age-related macular degeneration and diabetic retinopathy. This award was issued...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $14,917.20 by the Defense Logistics Agency (DLA) on September 15, 2025. The delivery order, which has an ultimate completion date of October 6, 2025, covers the supply of Vabysmo 6 mg/0.05 mL syringes for delivery to Park Ridge, Illinois. This award was issued without a set-aside designation, allowing the contractor to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $29.8K on July 21, 2025, for the supply of Vabysmo 6 mg/0.05 mL syringes. This firm fixed-price delivery order is set to be completed by August 11, 2025, and represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program. The parent contract,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,966.88 by the Defense Logistics Agency on August 26, 2025. The delivery order covers VABYSMO 6 mg/0.05 mL syringes, a prescription pharmaceutical product, with an ultimate completion date of September 17, 2025. This award was not issued under a set-aside designation, allowing the vendor to compete directly in the open...
- SPE2DB25D9305Indefinite Delivery Contract
- SPE2DB25D9305-SPE2DB26FQAAJDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,458.40 by the Defense Logistics Agency on October 21, 2025, for VABYSMO 6 mg/0.05 mL vials. This delivery order, which carries no set-aside designation, is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The IDC, designated as contract SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 with a completion date of December 31, 2036, positioning the company as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. The PPV-G GEN V program authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders to DMS Pharmaceutical Group for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support military healthcare facilities worldwide. This delivery order for VABYSMO, an ophthalmic pharmaceutical, reflects the company's established capability to supply specialized pharmaceutical products for Department of Defense medical operations. With ultimate completion scheduled for November 12, 2025, and place of performance in Park Ridge, Illinois, this award demonstrates DMS Pharmaceutical Group's ongoing role as a critical supplier within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/21/25 |